Core 1: Diabetes, GI & Nutrition, Ziegler
核心 1:糖尿病、胃肠道
基本信息
- 批准号:10260485
- 负责人:
- 金额:$ 17.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-10 至 2023-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdultAdverse eventAffectAreaBeta CellBiologicalBiological AssayBloodBody CompositionBody fatCaringCell physiologyChildChildhoodChronicClinicalClinical DataClinical InformaticsClinical ResearchCollaborationsCommunitiesConsultationsCystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorDataData AnalysesDiabetes MellitusDiagnosticDiagnostic ProcedureDoctor of PhilosophyEarly DiagnosisEndocrineEnergy MetabolismFacultyFutureGastrointestinal DiseasesGlucose IntoleranceGoalsHealthHepaticImageImpairmentIndividualInterdisciplinary StudyKnowledgeLeadershipLinkLiverLiver diseasesLongevityLung diseasesMaintenanceMeasurementMetabolismMicronutrientsMissionModalityMorbidity - disease rateNational Institute of Diabetes and Digestive and Kidney DiseasesNatureNutritionalNutritional statusOGTTOutcomePersonsPhenotypePlayProteinsQuality of lifeReproductive HealthResearchResearch DesignResearch PersonnelResearch PriorityResearch SupportResearch TrainingResourcesRoleSamplingScientistServicesSpecimenTechnologyTeenagersTestingTissuesTrainingTraining and EducationTranslational ResearchTranslationsUniversitiesVisitWithdrawalbaseboneclinical data warehousecohortcomorbiditycystic fibrosis patientscystic fibrosis related diabetesdata repositorydata warehouseeffective therapyexperiencegastrointestinalgraduate studentinsulin sensitivityinterestmicrobiomenovelnutrient absorptionnutritionoutreachsexside effecttooltraining opportunitytranslational scientistundergraduate student
项目摘要
PROJECT SUMMARY – Core 1: Diabetes, GI, and Nutrition Core
Major advances in the management of pulmonary disease in cystic fibrosis (CF) have led to a needed redirection
of research to non-pulmonary comorbidities. Critical knowledge gaps exist in three key areas: 1) chronic
endocrine complications, including CF-related diabetes (CFRD); 2) gastrointestinal (GI) and hepatic
manifestations, including CF-related liver disease (CFLD); and 3) assessment and optimization of nutritional
status. Individuals living with CF commonly experience comorbidities in one or more of these domains that
significantly impair their overall quality of life and can reduce their long-term survival. In addition, little research
has yet been conducted relevant to endocrine, GI, or nutritional issues in CF patients receiving CFTR modulators.
The major goal of the Diabetes, GI, and Nutrition (DGN) Core of the Georgia CF Research and Translation Core
Center (Georgia CF Core Center) is to support the research and training of clinical and translational scientists in
non-pulmonary, NIDDK mission-related research in children and adults with CF. The DGN Core will consist of
three integrated Sub-Cores, each providing unique and complementary faculty expertise and resources. These
are: 1) Diabetes/Endocrine Sub-Core, 2) GI/Liver Sub-Core, and 3) Nutrition Sub-Core. The nature of the
research supported by the DGN Sub-Cores is conducive to integrative interactions between each Sub-Core and
with all other activities in our proposed Georgia CF Core Center. Each DGN Sub-Core will provide novel serial
data obtained from annual research oral glucose tolerance test visits in children and adults with CF to the Georgia
CF Data Warehouse, a state-wide data repository proposed by the Clinical Research and Informatics Core. We
hypothesize that the DGN Core will lead to: 1) more impactful CF research; 2) more investigators new to CF
performing multi-disciplinary research; 3) new collaborations linking DGN Core leadership and users to internal
and external CF investigators; and 4) earlier detection, better diagnostics, and better treatment of CF
comorbidities. We propose four specific aims to meet the goals of the DGN Core:
Specific Aim 1: To provide a novel platform for established and new CF investigators wanting to incorporate
diabetes, bone, sex/reproductive health, and other endocrine endpoints into their research (Diabetes/Endocrine
Sub-Core).
Specific Aim 2: To aid CF investigators interested in CF GI/liver disease with access to state-of-the-art tools
and measurements, study design guidance, and data interpretation services (GI/Liver Sub-Core).
Specific Aim 3: To provide scientists performing CF research with access to state-of-the-art tools and
measurements, study design guidance, and data interpretation services related to nutrition and body composition
outcomes (Nutrition Sub-Core).
Specific Aim 4: To provide education, training and critical new outreach to promote interest and maximize DGN
Core usage for clinical and translational research in CF across the lifespan.
项目摘要 - 核心1:糖尿病,GI和营养核心
囊性纤维化(CF)管理肺部疾病治疗的重大进展已导致需要重定向
非肺合并症的研究。关键知识差距存在三个关键领域:1)慢性
内分泌并发症,包括与CF相关的糖尿病(CFRD); 2)胃肠道(GI)和肝
表现,包括与CF相关的肝病(CFLD); 3)营养评估和优化
地位。具有CF共同经验的个人合并症
大大损害其整体生活质量,并可以减少其长期生存。此外,很少的研究
尚未与接收CFTR调节剂的CF患者中的内分泌,GI或营养问题有关。
佐治亚州CF研究和翻译核心的糖尿病,GI和营养(DGN)核心的主要目标
中心(佐治亚州CF核心中心)是为了支持临床和翻译科学家的研究和培训
CF的儿童和成人的非肺,NIDDK任务相关的研究。 DGN核心将包括
三个集成子核,每个核心提供独特而完整的教师专业知识和资源。这些
为:1)糖尿病/内分泌子核,2)GI/肝脏子核和3)营养子核。的本质
DGN子核支持的研究是针对每个子核和
在我们拟议的佐治亚州CF核心中心中,所有其他活动。每个DGN子核将提供新颖的串行
从年度研究的儿童和成人对佐治亚州的儿童和成人进行口服葡萄糖耐量测试访问获得的数据
CF Data Warehouse是临床研究和信息学核心提出的全州数据存储库。我们
假设DGN核心将导致:1)更具影响力的CF研究; 2)更多新的调查员
进行多学科研究; 3)将DGN核心领导和用户与内部用户联系起来的新合作
和外部CF调查人员; 4)早期检测,更好的诊断和更好的CF治疗
合并症。我们提出了四个具体目标,以实现DGN核心的目标:
特定目的1:为已建立和新的CF调查人员提供新颖的平台,希望合并
糖尿病,骨骼,性别/生殖健康和其他内分泌终点(糖尿病/内分泌)
子核)。
特定目的2:帮助对CF GI/肝脏疾病感兴趣的CF调查人员使用最先进的工具
以及测量,研究设计指南和数据解释服务(GI/肝脏子核)。
特定目的3:为科学家提供CF研究,并使用最先进的工具和
与营养和身体成分有关的测量,研究设计指导以及数据解释服务
结果(营养子核)。
特定目标4:提供教育,培训和关键的新外展活动以促进兴趣和最大的DGN
整个生命周期中CF的临床和翻译研究的核心用法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Thomas R Ziegler其他文献
Thomas R Ziegler的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Thomas R Ziegler', 18)}}的其他基金
Comparative effectiveness of energy dose in critical illness
能量剂量在危重疾病中的比较效果
- 批准号:
8114637 - 财政年份:2011
- 资助金额:
$ 17.8万 - 项目类别:
Comparative effectiveness of energy dose in critical illness
能量剂量在危重疾病中的比较效果
- 批准号:
8294603 - 财政年份:2011
- 资助金额:
$ 17.8万 - 项目类别:
Efficacy and Mechanisms of GLN Dipeptide in the SICU
GLN二肽在SICU中的疗效及机制
- 批准号:
7908371 - 财政年份:2009
- 资助金额:
$ 17.8万 - 项目类别:
相似国自然基金
成人型弥漫性胶质瘤患者语言功能可塑性研究
- 批准号:82303926
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
- 批准号:82302025
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
融合多源异构数据应用深度学习预测成人肺部感染病原体研究
- 批准号:82302311
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Dose Flexible Combination 3D-Printed Delivery Systems for Antiviral Therapy in Children
用于儿童抗病毒治疗的剂量灵活组合 3D 打印输送系统
- 批准号:
10682185 - 财政年份:2023
- 资助金额:
$ 17.8万 - 项目类别:
A Novel VpreB1 Anti-body Drug Conjugate for the Treatment of B-Lineage Acute Lymphoblastic Leukemia/Lymphoma
一种用于治疗 B 系急性淋巴细胞白血病/淋巴瘤的新型 VpreB1 抗体药物偶联物
- 批准号:
10651082 - 财政年份:2023
- 资助金额:
$ 17.8万 - 项目类别:
Early life stress impacts molecular and network properties that bias the recruitment of pro-stress BLA circuits
早期生活压力会影响分子和网络特性,从而影响促压力 BLA 回路的募集
- 批准号:
10820820 - 财政年份:2023
- 资助金额:
$ 17.8万 - 项目类别:
Developing a Risk Index for Functional Decline in Middle-Aged and Older Adults with HIV
制定中老年艾滋病毒感染者功能衰退的风险指数
- 批准号:
10762280 - 财政年份:2023
- 资助金额:
$ 17.8万 - 项目类别:
Development and implementation of a digital sleep intervention for preschoolers in foster care
为寄养中的学龄前儿童开发和实施数字睡眠干预
- 批准号:
10724304 - 财政年份:2023
- 资助金额:
$ 17.8万 - 项目类别: